Literature DB >> 20805699

Single nucleotide polymorphisms in the phospholipase A2 receptor gene are associated with genetic susceptibility to idiopathic membranous nephropathy.

Sejoong Kim1, Ho Jun Chin, Ki Young Na, Suhnggwon Kim, Jieun Oh, Wookyung Chung, Jung Woo Noh, Young Ki Lee, Jong Tae Cho, Eun Kyoung Lee, Dong-Wan Chae.   

Abstract

BACKGROUND: The phospholipase A(2) receptor (PLA2R) is a major antigen found in patients with idiopathic membranous nephropathy (MN). The relationship of genetic polymorphisms of PLA2R with the susceptibility and clinical outcomes of this disease is unknown.
METHODS: We studied 199 patients with idiopathic MN followed up for 3.7 ± 3.2 years. We enrolled 33 patients with secondary MN and 356 subjects with normal blood pressure and no proteinuria. PLA2R single nucleotide polymorphisms (SNPs) were genotyped.
RESULTS: The allele frequencies of C in rs35771982 and G in rs3828323 were 73.6 and 73.9%, respectively. Subjects with the CC genotype in rs35771982 had a higher susceptibility to idiopathic MN compared to subjects with other genotypes (odds ratio 2.6; 95% confidence interval 1.8-4.0). Patients with secondary MN were not different from controls with regard to PLA2R genotype. No impact of genetic polymorphisms on renal survival was detected.
CONCLUSION: The findings of this study suggest that PLA2R SNPs might be associated with the risk of developing MN.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20805699     DOI: 10.1159/000320194

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  33 in total

1.  Efficacy and safety of tacrolimus vs. cyclophosphamide for idiopathic membranous nephropathy: A meta-analysis of Chinese adults.

Authors:  Zhen-Qiong Li; Man-Li Hu; Chun Zhang; Yu-Mei Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-10-22

2.  Can genetics risk-stratify patients with membranous nephropathy?

Authors:  Andrew S Bomback; Ali G Gharavi
Journal:  J Am Soc Nephrol       Date:  2013-07-05       Impact factor: 10.121

Review 3.  A systems view of genetics in chronic kidney disease.

Authors:  Benjamin J Keller; Sebastian Martini; John R Sedor; Matthias Kretzler
Journal:  Kidney Int       Date:  2011-10-19       Impact factor: 10.612

Review 4.  Genetics of kidney failure and the evolving story of APOL1.

Authors:  David J Friedman; Martin R Pollak
Journal:  J Clin Invest       Date:  2011-09-01       Impact factor: 14.808

5.  Phospholipase A2 receptor (PLA2R1) sequence variants in idiopathic membranous nephropathy.

Authors:  Marieke J H Coenen; Julia M Hofstra; Hanna Debiec; Horia C Stanescu; Alan J Medlar; Bénédicte Stengel; Anne Boland-Augé; Johanne M Groothuismink; Detlef Bockenhauer; Steve H Powis; Peter W Mathieson; Paul E Brenchley; Robert Kleta; Jack F M Wetzels; Pierre Ronco
Journal:  J Am Soc Nephrol       Date:  2013-02-21       Impact factor: 10.121

Review 6.  Pathogenesis of membranous nephropathy: recent advances and future challenges.

Authors:  Pierre Ronco; Hanna Debiec
Journal:  Nat Rev Nephrol       Date:  2012-02-28       Impact factor: 28.314

7.  The dominant humoral epitope in phospholipase A2 receptor-1: presentation matters when serving up a slice of π.

Authors:  Laurence H Beck
Journal:  J Am Soc Nephrol       Date:  2014-10-06       Impact factor: 10.121

8.  Analysis of PLA2R1 and HLA-DQA1 sequence variants in Japanese patients with idiopathic and secondary membranous nephropathy.

Authors:  Hajime Kaga; Atsushi Komatsuda; Ayumi Omokawa; Shin Okuyama; Kensuke Mori; Hideki Wakui; Naoto Takahashi
Journal:  Clin Exp Nephrol       Date:  2017-08-28       Impact factor: 2.801

Review 9.  Membranous nephropathy: the start of a paradigm shift.

Authors:  Sandra M S Herrmann; Sanjeev Sethi; Fernando C Fervenza
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-03       Impact factor: 2.894

Review 10.  Unmet challenges in membranous nephropathy.

Authors:  David J Salant
Journal:  Curr Opin Nephrol Hypertens       Date:  2019-01       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.